AIA Group »

United Therapeutics Corporation shares owned by AIA Group

Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by AIA Group from 13F filings

Historical chart of AIA Group investment in United Therapeutics Corporation

Tip: Access up to 7 years of quarterly data

All positions including United Therapeutics Corporation held by AIA Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in United Therapeutics Corporation by AIA Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $974k 2.0k 487.25
2025-09-30 $545k 1.3k 419.21
2024-12-31 $215k 608 352.84
2023-03-31 $896k 4.0k 223.96
2020-12-31 $680k 4.0k 170.00

More positions owned by AIA Group

Ishares Tr Core S&p500 Etf (IVV)
Invesco Qqq Tr Unit Ser 1 (QQQ)
2023 Etf Series Trust Ii Gmo Us Quality E (QLTY)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Russell 2000 Etf (IWM)
Meta Platforms Cl A (META)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Apple (AAPL)
Broadcom (AVGO)
Amazon (AMZN)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
NVIDIA Corporation (NVDA)
Johnson & Johnson (JNJ)
Visa Com Cl A (V)

View all positions for AIA Group

Top funds holding United Therapeutics Corporation

BlackRock
Vanguard Group
venBio Select Advisor
Renaissance Technologies
State Street Corporation
Wellington Management Company
Geode Capital Management
AQR Capital Management
Assetmark
Invesco
Norges Bank Investment Management
Dimensional Fund Advisors
Susquehanna International
Henderson Group
Citadel Advisors

View all funds holding United Therapeutics Corporation